ADIM
EMN icon

Alpha DNA Investment Management’s Eastman Chemical EMN Stock Holding History

Alpha DNA Investment Management’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-419
Closed -$46K – 266
2021
Q1 		$46K Buy
419
+94
+29% +$10.2K 0.05% 184
2020
Q4 		$32K Buy
+325
New +$30.1K 0.03% 218

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Alpha DNA Investment Management's EMN Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Eastman Chemical (EMN) in Q2 2021, closing a stake of 419 shares — an estimated $46K sold.

Alpha DNA Investment Management first reported a position in EMN in Q4 2020 and held it in 2 quarters. The position peaked at $46K in Q1 2021. 723 funds tracked by Wall St. Rank hold EMN as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Eastman Chemical position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 419 Eastman Chemical shares in Q2 2021, an estimated $46K.
  • Alpha DNA Investment Management first reported a position in Eastman Chemical in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Eastman Chemical position peaked at $46K in Q1 2021.
  • 723 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.